HIBBS KATHY L sold $48K of SOPH
HIBBS KATHY L sold 6,250 shares of SOPHiA GENETICS SA (SOPH) at $7.76 on 2026-11-10 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale adds a modest supply side pressure but is unlikely to move the stock significantly.
Market read
A small insider sell; limited trading relevance unless part of a larger pattern.
What to watch
Potential upcoming corporate actions or financing needs not disclosed in the filing.
Background
SEC Form 4 filings disclose insider transactions; investors monitor them for signals of confidence or concern.
Ticker impact
Director Kathy L. Hibbs sold 6,250 shares for $48,477 via a 10b5‑1 plan, reducing her stake to 90,742 shares.
likely slight downward pressure as the market prices the insider sell
Form 4 filing is a primary source; the transaction size is small but indicates insider intent to reduce exposure.
Market effects
Minimal impact on the broader genomics sector; isolated insider activity.
Limited to SOPH's trading on US exchanges.
Low; does not affect global market dynamics.
Counterpoint
The sale may be routine under a pre‑arranged plan and not a signal of negative fundamentals.
Key entities
- CompanySOPHiA GENETICS SA
Swiss genomics data analytics firm listed on NASDAQ under SOPH.
- InsiderKathy L. Hibbs
Director of SOPHiA GENETICS SA.



